Click Here for 5% Off Your First Aladdin Purchase!

CC-401 - ≥98%, high purity , CAS No.395104-30-0, Inhibitor of maternal embryonic leucine zipper kinase

  • Moligand™
  • ≥98%
Item Number
C339031
Grouped product items
SKUSizeAvailabilityPrice Qty
C339031-2mg
2mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$314.90
C339031-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,007.90

an ATP-competitive JNK inhibitor

Basic Description

SynonymsCC-401|395104-30-0|3-(3-(2-(piperidin-1-yl)ethoxy)phenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole|NOE38VQA1W|3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole|3-[3-[2-(1-PIPERIDINYL)ETHOXY]PHENYL]-5-(1H-1,2,4-TRIAZOL-5-YL)-1H-INDAZO
Specifications & PurityMoligand™, ≥98%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of maternal embryonic leucine zipper kinase
Product Description

CC-401 is a second generation ATP-competitive anthrapyrazolone JNK (c-Jun N terminal kinase) inhibitor with potential antineoplastic activity.

Product Properties

ALogP3.8

Names and Identifiers

IUPAC Name 3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole
INCHI InChI=1S/C22H24N6O/c1-2-9-28(10-3-1)11-12-29-18-6-4-5-16(13-18)21-19-14-17(22-23-15-24-27-22)7-8-20(19)25-26-21/h4-8,13-15H,1-3,9-12H2,(H,25,26)(H,23,24,27)
InChi Key XDJCLCLBSGGNKS-UHFFFAOYSA-N
Canonical SMILES C1CCN(CC1)CCOC2=CC=CC(=C2)C3=NNC4=C3C=C(C=C4)C5=NC=NN5
Isomeric SMILES C1CCN(CC1)CCOC2=CC=CC(=C2)C3=NNC4=C3C=C(C=C4)C5=NC=NN5
Alternate CAS 395104-30-0
PubChem CID 10430360
MeSH Entry Terms CC 401;CC-401;CC401 cpd
Molecular Weight 388.47

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilitySoluble in DMSO.

Related Documents

References

1. Abdolazimi Y, Zhao Z, Lee S, Xu H, Allegretti P, Horton TM, Yeh B, Moeller HP, Nichols RJ, McCutcheon D et al..  (2018)  CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition..  Endocrinology,  159  (9): (3143-3157).  [PMID:29514186]
2. Han SY.  (2008)  c-Jun N-Terminal Kinase Signaling Inhibitors Under Development..  Toxicol Res,  24  (2): (93-100).  [PMID:32038782]

Solution Calculators